Tetracera billardierei
Tetracera billardierei · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Tetracera billardierei is a botanical species that has gained significant scientific interest due to its diverse range of pharmacological properties. Research has highlighted its potential biological activities, including antibacterial, anticancer, anti-HIV, and anthelmintic effects. Specifically, the ethanol extract derived from the plant's leaves has shown promise in medicinal applications. One notable area of investigation involves its ability to manage conditions such as Diabetes Mellitus. Consequently, this plant represents a valuable subject for ongoing studies in natural drug development.
- Synonyms
- Euryandra Scandens
- Common names
- Not available
- Family
- Dilleniaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Tetracera billardierei is a botanical species that is also recognized by its scientific synonym, Euryandra scandens. This nomenclatural overlap can sometimes cause confusion for researchers studying its specific classification. Understanding these taxonomic connections is essential for maintaining accurate records within botanical databases. By identifying both names, botanists can ensure they are referencing the correct plant during field studies. Ultimately, recognizing these synonymous relationships helps clarify the evolutionary history and naming conventions of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tetracera billardierei is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the specific order Dilleniales, which helps define its evolutionary lineage. Furthermore, this plant is a part of the Dilleniaceae family. Ultimately, its botanical identity is solidified by its placement within the genus Tetracera.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Dilleniales |
| Family | Dilleniaceae |
| Genus | Tetracera |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Tetracera billardierei is a notable plant species with a widespread presence across several distinct geographic regions. Within the Asian tropical zone, it can be found extensively throughout Indo-China and specifically within the landscapes of Laos. Its reach also extends significantly into the Pacific, covering much of the Southwestern Pacific area. Notably, the species maintains a stable distribution in New Caledonia as well. This diverse range highlights the plant's ability to thrive in varied tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Tetracera billardierei belongs to a genus of plants that holds significant promise for managing metabolic disorders. Recent scientific interest has focused on related species like Tetracera scandens, which has been traditionally utilized for its antidiabetic properties. Research into these plants has revealed that their leaf extracts possess potent inhibitory effects against α-glucosidase, an enzyme key to regulating blood sugar levels. Through advanced GC-MS metabolite profiling, scientists have identified specific metabolites responsible for this therapeutic activity. These findings underscore the potential of the Tetracera genus to contribute valuable bioactive compounds to modern antidiabetic treatments.
Compounds
Conditions
Tetracera billardierei demonstrates significant therapeutic potential by effectively treating HIV virus replication through its specialized medicinal properties. The plant acts as a potent HIV-1 inhibitor, specifically targeting the biological mechanisms of the virus. It provides treatment for HIV-1 reverse transcriptase (RTase), which helps prevent the production of viral cDNA. Additionally, its overall anti-HIV efficacy makes it a promising candidate for the development of new antiviral medications. Beyond viral treatments, the plant is also recognized for its ability to treat diabetes mellitus by utilizing α-glucosidase inhibitory metabolites.
Preparations
Tetracera billardierei is prepared as an ethanol extract to study its potential medicinal properties. This specific preparation method allows researchers to isolate bioactive compounds from the plant material. The resulting liquid solution serves as the primary medium for testing various biological activities. By using ethanol, the extract captures a wide range of phytochemicals necessary for subsequent analysis. Such preparation is a fundamental step in evaluating the plant's pharmacological potential.
Parts used
Tetracera billardierei is a plant species that possesses leaves as a key anatomical part. While research often focuses on closely related species like Tetracera scandens, the structural importance of the leaf remains a common theme in botanical studies. In the case of Tetracera scandens, the leaves serve as a vital source of medicinal metabolites used for managing diabetes. Scientific investigations utilize techniques like GC-MS profiling to identify specific compounds within these leafy extracts. Ultimately, understanding the relationship between these plants and their leaf components is essential for discovering new therapeutic potentials.